Aurore Life Sciences is a pure-play API and intermediates manufacturer with a robust product portfolio of 40+ commercially produced APIs across a wide range of therapeutic categories. We are completely Backward – Integrated in all our APIs ensuring a seamless manufacturing pipeline with no external constraints. Our operations are backed by two state-of-the-art manufacturing sites with a combined capacity of 800 KL where one of which is USFDA approved and two Intermediate sites to support us. Our dedicated R&D facility with over 120 experienced chemists enables us to conduct faster product development with a focus on cost reduction and developing competitive products. Strict adherence and compliance to cGMP practices have secured us multiple regulatory approvals such as USFDA, EDQM, WHO Geneva, ANVISA, etc which enabled us to be a trusted vendor for leading pharmaceutical companies worldwide.